All Articles

Train of Glamour joins the prestigious EHL Alliance, becoming its first Chinese member and signaling a new era for luxury travel on its Silk Road Express.

The national firm adds partners Allison Rule and Michael Donahue, signaling a deep push into tech regulation and highlighting the appeal of its modern structure.

A new bispecific antibody, EPI-326, enters human trials, hoping its unique tissue-selective degradation can defeat EGFR-driven cancers where others fail.

Ibero Mining has secured C$500,000 in a critical financing deal aimed at resolving regulatory issues and advancing its gold and copper projects in Portugal.

As it files to go public, Fervo Energy is betting its advanced geothermal tech can deliver 24/7 clean power and win over investors in a hot IPO market.

Suunto's new Spark headphones bring air-conduction audio and integrated running metrics to athletes, promising immersive sound without sacrificing awareness.

A new three-way partnership aims to create a seamless, high-tech "one-stop shop" for MICE clients at a luxury Fort Canning venue.

The wellness company faces a tough year with an 8.3% sales drop, operational missteps, and mounting questions about its financial stability.

Japan Smaller Capitalization Fund announces a 10% share tender offer to address a steep discount, creating a critical decision point for its investors.

Amid strong investor demand, RPX Gold increases its capital raise to C$12.3M, signaling a major push for its promising Wawa Gold Project in Ontario.

As Instagram's algorithm evolves, brands face new challenges. Agencies like True North Social are expanding services to master video, data, and authenticity.

Health advocates decry India's proposal to limit access to nicotine gums and lozenges, calling it 'public health madness' while cigarettes remain ubiquitous.

Long Beach City College's voter-funded upgrades, from a state-of-the-art arts center to new trade facilities, have won three prestigious regional awards.

The handbag maker's board has terminated its shareholder rights plan, a move signaling confidence but also opening the door to potential M&A activity.

As Surgery Partners sets its Q1 2026 earnings call, investors are watching closely to see if it can overcome recent headwinds and capitalize on industry trends.

New preclinical data reveals a novel drug, rinzimetostat, may overcome treatment resistance in prostate cancer by targeting a unique molecular switch.

Kairos Power begins construction on its Hermes 2 plant, the first power-producing Gen IV reactor in the US, promising a new era of clean, affordable energy.

A new gene therapy that reprograms cancer cells into immune activators shows major promise, blending personalized treatment with off-the-shelf convenience.

Boston's Crestwood Advisors earns a repeat spot on USA TODAY's top financial firms list, proving consistent growth and a client-first model are key.

A new AI trading bot promises hands-free profits, but a lack of regulatory oversight and performance data raises critical questions for new investors.